JTCS Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hope, A. F.
Right arrow Articles by Minnaar, P. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hope, A. F.
Right arrow Articles by Minnaar, P. C.

The Journal of Thoracic and Cardiovascular Surgery, Vol 81, 880-886, Copyright © 1981 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association


ARTICLES

Kinetics and sites of sequestration of indium 111-labeled human platelets during cardiopulmonary bypass

AF Hope, AD Heyns, MG Lotter, OR van Reenen, F de Kock, PN Badenhorst, H Pieters, H Kotze, JM Meyer and PC Minnaar

A new approach for the study of the kinetics and quantification of the in vivo and ex vivo sites of sequestration of platelets during cardiopulmonary bypass (CPB) is described. Autologous platelets of four patients were labeled with 111In-oxine and reinfused on the day prior to CPB for coronary artery bypass grafting. Changes in blood 111In- labeled platelet radioactivity and blood platelet counts were monitored during the operation. In vivo 111In-labeled platelet redistribution was quantified with a scintillation camera and a computer-assisted imaging system before and after CPB. Sequestration of 111In-labeled platelets in the bubble oxygenator was measured. 111In-labeled platelet activity in the blood decreased by 46% +/- 5% within 5 minutes of CPB, but this decrease was mostly due to hemodilution; the true loss of platelets from the circulation was 13% +/- 4%. Intraoperatively, whole body 111In activity decreased by oxygenator 10.8% +/- 1.3% of administered platelets were sequestered, especially in the innermost active layers of the defoaming mesh of the bubble oxygenator. Mean survival time of circulating platelets was 58 +/- 8 hours and fitted an exponential function best. The bleeding time increased to 40 minutes during operation and returned to normal within 24 hours. During operation 111In-labeled platelets accumulated somewhat in the liver (10.7%) but not in the spleen, thorax, or head. In the 48 hours after operation, platelets were sequestered mainly in the liver. The scintillation camera with computer-assisted imaging allows in vivo quantitative studies of platelet kinetics of a type which has not been possible with previous techniques.


This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
E. W. Muriithi, P. R. Belcher, J. N. Rao, M. A. Chaudhry, D. Nicol, and D. J. Wheatley
The effects of heparin and extracorporeal circulation on platelet counts and platelet microaggregation during cardiopulmonary bypass
J. Thorac. Cardiovasc. Surg., September 1, 2000; 120(3): 538 - 543.
[Abstract] [Full Text] [PDF]


Home page
PerfusionHome page
J. A. Hyde, J. A Chinn, and T. R Graham
Platelets and cardiopulmonary bypass
Perfusion, December 1, 1998; 13(6): 389 - 407.
[PDF]


Home page
Ann. Thorac. Surg.Home page
M. K. Dewanjee
Stroke From Heparin-Coated Circuits and Reduced Systemic Anticoagulation
Ann. Thorac. Surg., October 1, 1997; 64(4): 1218 - 1219.
[Full Text]


Home page
CirculationHome page
G. Wernovsky, D. Wypij, R. A. Jonas, J. E. Mayer Jr, F. L. Hanley, P. R. Hickey, A. Z. Walsh, A. C. Chang, A. R. Castaneda, J. W. Newburger, et al.
Postoperative Course and Hemodynamic Profile After the Arterial Switch Operation in Neonates and Infants : A Comparison of Low-Flow Cardiopulmonary Bypass and Circulatory Arrest
Circulation, October 15, 1995; 92(8): 2226 - 2235.
[Abstract] [Full Text]


Home page
PerfusionHome page
P. Kesteven
Haemostatic changes during cardiopulmonary bypass
Perfusion, January 1, 1990; 5(1_suppl): 9 - 19.
[PDF]


Home page
PerfusionHome page
D.T. Pearson and B. McArdle
Haemocompatibility of membrane and bubble oxygenators
Perfusion, January 1, 1989; 4(1): 9 - 24.
[Abstract] [PDF]


Home page
PerfusionHome page
D. He and L. Hou
Effects of high dose ascorbic acid on haemostasis during and after cardiopulmonary bypass
Perfusion, October 1, 1988; 3(4): 281 - 286.
[Abstract] [PDF]


Home page
PerfusionHome page
T. Spyt, D. Wheatley, I. Walker, J. Davidson, K. MacArthur, and W. Martin
Placebo-controlled study of Iloprost (ZK 36374) in cardiopulmonary bypass surgery
Perfusion, July 1, 1988; 3(3): 179 - 186.
[Abstract] [PDF]


Home page
PerfusionHome page
D. T Pearson, B. McArdle, S. J Poslad, and A. Murray
A clinical evaluation of the performance characteristics of one membrane and five bubble oxygenators: haemocompatibility studies
Perfusion, January 1, 1986; 1(2): 81 - 98.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1981 by The American Association for Thoracic Surgery.